Xiao Feng, Ph.D.Vice President, Head of Research at Zenas BioPharmaSpeaker
Profile
Dr. Xiao Feng is Vice President, Head of Research at Zenas BioPharma. Prior to joining Zenas, he served as Executive Director, Toxicology and DMPK at Boston Pharmaceuticals. Previously, Dr. Feng was the Senior Director of Toxicology and DMPK at Corbus Pharmaceuticals.
Dr. Feng has over 20 years of experience in the biopharmaceutical industry from early discovery to late stage drug development support including commercialization to life cycle management.
He has led Nonclinical Development for multiple programs from IND-enabling through successful registration. Dr. Feng received a Ph.D. in Cell Biology from Duke University, and an M.S. and B.S. in Genetics and Biology, respectively, from Fudan University.
Agenda Sessions
Obexelimab: A Differentiated B cell Targeted Antibody for Treatment of Autoimmune Diseases
, 3:30pmView Session